Cantech Letter

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. /CNW/ — USANewsGroup.com News Commentary – The oncology landscape is entering a high-velocity regulatory phase as genomics ...